GMSbiotech, PTS Partner to Develop Array-based Antibody Screening Solution | GenomeWeb

NEW YORK (GenomeWeb News) – GMSbiotech and Pure Transplant Solutions today announced a partnership to develop a new antibody screening solution.

The partnership leverages GMSbiotech's microarray-based diagnostic platform for personalized medicine and transplantation compatibility and PTS' HLA reagents, which include more than 200 Class I and II alleles. That number is anticipated to grow to more than 300 alleles during the course of the deal announced today, GMSbiotech and PTS said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.